ANALYSIS OF THE BUDGET IMPACT OF SECUKINUMAB USE VERSUS ANTI-TNF AGENTS IN ANKYLOSING SPONDYLITIS PATIENTS

被引：0
|
作者：
Romero Prada, M. E. [1 ]
Roa, Cardenas N. C. [1 ]
Serrano, G. Y. [1 ]
Huerfano, L. M. [1 ]
机构：
[1] Salutia Fdn, Res Ctr Econ Management & Hlth Technol, Bogota, Colombia
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS11
引用
收藏
页码：A937 / A937
页数：1
相关论文
共 50 条
  • [1] An audit of the use of anti-TNFα agents in ankylosing spondylitis( AS)
    Trebilcock, Emily
    Rankin, Elizabeth
    RHEUMATOLOGY, 2008, 47 : II65 - II65
  • [2] Treatment of ankylosing spondylitis with anti-TNFα agents
    Bontoux, Daniel
    Azais, Isabelle
    Goupille, Philippe
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (4-5): : 981 - 992
  • [3] Budget impact analysis of secukinumab versus adalimumab in the treatment of ankylosing spondylitis
    Purmonen, Timo
    Tormalehto, Soili
    Wahlman, Hanna
    Puolakka, Kari
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (02) : 151 - 157
  • [4] Compliance with NICE guidance on the use of anti-TNF agents in ankylosing spondylitis
    Madan, Ayesha
    CLINICAL MEDICINE, 2012, 12 (06) : 603 - 603
  • [5] International ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
    Braun, J
    Pham, T
    Sieper, J
    Davis, J
    van der Linden, S
    Dougados, M
    van der Heijde, D
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 55 - 55
  • [6] Treatment of ankylosing spondylitis with anti-TNFα agents -: Discussion
    Serratrice, M. Georges
    Bastin, M. Raymond
    Godeau, M. Pierre
    Bourel, M. Michel
    Doury, M. Paul
    Paolaggi, M. Jean-Baptiste
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (4-5): : 993 - 994
  • [7] BUDGET IMPACT OF SECUKINUMAB FOR ANKYLOSING SPONDYLITIS IN THE UK
    Halliday, A.
    Hacking, V
    Jugl, S. M.
    Gunda, P.
    Nikoglou, E.
    Miles, L.
    Graham, C. N.
    VALUE IN HEALTH, 2016, 19 (07) : A535 - A535
  • [8] A BUDGET IMPACT ANALYSIS OF SECUKINUMAB IN THE MANAGEMENT OF ANKYLOSING SPONDYLITIS IN GREECE
    Kousoulakou, H.
    Geitona, M.
    Chatzikou, M.
    Doukoumetzidis, K.
    Patrikos, D.
    VALUE IN HEALTH, 2016, 19 (07) : A533 - A533
  • [9] First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
    Braun, J
    Davis, J
    Dougados, M
    Sieper, J
    van der Linden, S
    van der Heijde, D
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (03) : 316 - 320
  • [10] The anti-TNF revolution in ankylosing spondylitis
    Schachna, L
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (10) : 529 - 530
12345